Literature DB >> 19879733

Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy.

Woo-In Yang1, Chi Young Shim, Young Jin Kim, Sung-Ai Kim, Sang Jae Rhee, Eui-Young Choi, Donghoon Choi, Yangsoo Jang, Namsik Chung, Seung-Yun Cho, Jong-Won Ha.   

Abstract

BACKGROUND: Despite the relatively benign course for the majority of patients with hypertrophic cardiomyopathy (HCM), this disease may cause sudden cardiac death and progressive heart failure (HF). The aim of this study was to investigate useful parameters for predicting adverse outcomes of HCM, including echocardiographic parameters, cardiac magnetic resonance (CMR), and clinical markers.
METHODS: Eighty-one patients with nonapical HCM (51 men; mean age, 57 +/- 14 years) who underwent CMR and echocardiography were prospectively evaluated. Cardiovascular events were defined as hospitalization for worsening HF, stroke, or cardiovascular death.
RESULTS: During the mean follow-up period of 41 +/- 17 months, there were 17 cardiovascular events (5 deaths, 7 hospitalizations for worsening HF, and 5 strokes). Univariate analysis showed that older age, atrial fibrillation, elevated E/E' ratio, increased left atrial (LA) volume index, presence of mitral regurgitation grade > 2, New York Heart Association class III or IV, and late gadolinium enhancement >or= 6% were associated with cardiovascular events. In multivariate Cox regression analysis, increased LA volume index was found to be an independent predictor of cardiovascular events (for each 5 mL/m(2) increase, hazard ratio, 1.28; 95% confidence interval, 1.10-1.48; P < .01). Increased LA volume index was also revealed to be an independent predictor for cardiovascular events other than death (for each 5 mL/m(2) increase, hazard ratio, 1.44; 95% confidence interval, 1.12-1.83; P < .01).
CONCLUSION: LA volume index is independently associated with adverse outcomes in patients with HCM and provides additional prognostic information.

Entities:  

Mesh:

Year:  2009        PMID: 19879733     DOI: 10.1016/j.echo.2009.09.016

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  26 in total

1.  Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients.

Authors:  Philippe Debonnaire; Joep Thijssen; Darryl P Leong; Emer Joyce; Spyridon Katsanos; Georgette E Hoogslag; Martin J Schalij; Douwe E Atsma; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Int J Cardiovasc Imaging       Date:  2014-02-06       Impact factor: 2.357

2.  Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure.

Authors:  Waqas Hanif; Linda Alex; Ya Su; Arti V Shinde; Ilaria Russo; Na Li; Nikolaos G Frangogiannis
Journal:  Cardiovasc Pathol       Date:  2017-06-21       Impact factor: 2.185

3.  Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy.

Authors:  C Fielder Camm; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

4.  Comparison of echocardiographic single-plane versus biplane method in the assessment of left atrial volume and validation by real time three-dimensional echocardiography.

Authors:  Cesare Russo; Rebecca T Hahn; Zhezhen Jin; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  J Am Soc Echocardiogr       Date:  2010-07-21       Impact factor: 5.251

Review 5.  Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.

Authors:  Manhal Habib; Sara Hoss; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2019-06-26       Impact factor: 2.931

Review 6.  The role of echocardiography in hypertrophic cardiomyopathy.

Authors:  Lynne K Williams; Christiane H Gruner; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2015-02       Impact factor: 2.931

7.  Preoperative left atrial volume index predicts postoperative atrial fibrillation in patients with severe aortic valve stenosis.

Authors:  Yoshifumi Naito; Kazuo Yamazaki
Journal:  J Anesth       Date:  2013-03-19       Impact factor: 2.078

8.  Clinical Utility of Left Atrial Asynchrony and Mechanical Function in Patients with Hypertrophic Cardiomyopathy.

Authors:  Ozkan Candan; Cetin Gecmen; Muzaffer Kahyaoğlu; Zeki Şimsek; Mehmet Çelik; Abdulkadir Uslu; Cevat Kirma
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

9.  Left atrial structure and functional quantitation using cardiovascular magnetic resonance and multimodality tissue tracking: validation and reproducibility assessment.

Authors:  Mytra Zareian; Luisa Ciuffo; Mohammadali Habibi; Anders Opdahl; Elzbieta H Chamera; Colin O Wu; David A Bluemke; João A C Lima; Bharath Ambale Venkatesh
Journal:  J Cardiovasc Magn Reson       Date:  2015-07-01       Impact factor: 5.364

10.  Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model.

Authors:  Moumita Bhattacharya; Dai-Yin Lu; Ioannis Ventoulis; Gabriela V Greenland; Hulya Yalcin; Yufan Guan; Joseph E Marine; Jeffrey E Olgin; Stefan L Zimmerman; Theodore P Abraham; M Roselle Abraham; Hagit Shatkay
Journal:  CJC Open       Date:  2021-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.